{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-029190","form_type":"8-K","ticker":null,"cik":"0001531048","company_name":"Inari Medical, Inc.","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.914076+00:00","generated_at":"2026-05-26T11:38:20.794934+00:00","sec_items":["1.02","2.01","3.01","5.01","5.03","3.03","5.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Stryker completes $4.94B acquisition of Inari Medical; shares delisted","bullets":["Tender offer accepted 48.5M shares (81.69%) at $80.00/share; merger closed under DGCL 251(h).","Total aggregate consideration ~$4.94B cash; funded from Stryker cash and debt.","Inari Board resigned; William E. Berry Jr. and J. Andrew Pierce appointed directors; officers remain.","Shares to be delisted from Nasdaq; Form 15 to be filed to suspend SEC reporting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-029190","json":"https://secwatch.observer/filing/0001193125-25-029190.json","markdown":"https://secwatch.observer/filing/0001193125-25-029190.md","text":"https://secwatch.observer/filing/0001193125-25-029190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/d932380d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T11:38:20.794934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11841d6fba","claim":"Andrew Hykes resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"19ff893261","claim":"Robert K. Warner resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"235fce38ef","claim":"J. Andrew Pierce was appointed as Director at Inari Medical, Inc..","evidence_excerpt":"the directors of Merger Sub as of immediately prior to the Effective Time, William E. Berry Jr. and J. Andrew Pierce, became the directors of the Surviving Corporation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3c0f757e82","claim":"William E. Berry Jr. was appointed as Director at Inari Medical, Inc..","evidence_excerpt":"the directors of Merger Sub as of immediately prior to the Effective Time, William E. Berry Jr. and J. Andrew Pierce, became the directors of the Surviving Corporation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3e376536bd","claim":"Bill Hoffman resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"469bdff4dc","claim":"Jonathan Root resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4eda6b84cb","claim":"Donald Milder resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5d677ae6b4","claim":"Dana G. Mead, Jr. resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"abc79ec459","claim":"Catherine Szyman resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b6c64216b9","claim":"Cynthia Lucchese resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"be95e93d8a","claim":"Rebecca Chambers resigned as Director at Inari Medical, Inc..","evidence_excerpt":"Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2186aeef5663be69f41592692188f52e6d488f2a","claim":"Inari Medical, Inc.: Inari's certificate of incorporation was amended and restated in its entirety as of the Effective Time pursuant to the Merger Agreement.","evidence_excerpt":"as of the Effective Time, Inari’s certificate of incorporation was amended and restated in its entirety.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"411a429ef1d92c8bcc9d7b31fc331f215a4abc9c","claim":"Inari Medical, Inc.: Inari's bylaws were amended and restated in their entirety as of the Effective Time pursuant to the Merger Agreement.","evidence_excerpt":"as of the Effective Time, Inari’s bylaws were amended and restated in their entirety.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"}],"fact_type":"governance_change"},{"claim_id":"6b2d2e15e53e7a460fffef0b836a074e85ee447c","claim":"Inari Medical, Inc. underwent a change of control involving Stryker Corporation for $80.00 per Share, net to the seller in cash (closed 2025-02-19).","evidence_excerpt":"commenced a tender offer (the “ Offer ”) to purchase all of the issued and outstanding shares of Inari’s common stock, par value $0.001 per share (the “ Shares ”), at a price of $80.00 per Share, net to the seller in cash, without interest and subject to any applicable tax withholding (the “ Offer Consideration ”). The Offer expired as scheduled at one minute","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Stryker Corporation"},{"label":"Consideration","value":"$80.00 per Share, net to the seller in cash"},{"label":"Closing","value":"2025-02-19"}],"fact_type":"ma_transaction"},{"claim_id":"ee7b50d0900d7bebdf7886f00b8383fa59371e3d","claim":"Inari Medical, Inc. completed a disposition involving Stryker Corporation for approximately $4.94 billion in cash (closed 2025-02-19).","evidence_excerpt":"The total aggregate consideration paid by Merger Sub in the transaction was approximately $4.94 billion in cash.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Stryker Corporation"},{"label":"Consideration","value":"approximately $4.94 billion in cash"},{"label":"Closing","value":"2025-02-19"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}